Toxicity Results of A Phase 1 Safety Study of Pioglitazone as a Cytoprotective Agent Against Radiation-Induced Cognitive Decline
Sullivan, N. Alphonse, Page, B.R., Peiffer, A.M., Isom, S., Metheny-Barlow, L., Brown, D.R., Blackstock, A.W., Chan, M.D.Volume:
96
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2016.06.2119
Date:
October, 2016
File:
PDF, 57 KB
english, 2016